Product NDC: | 0037-2250 |
Proprietary Name: | Soma |
Non Proprietary Name: | Carisoprodol |
Active Ingredient(s): | 250 mg/1 & nbsp; Carisoprodol |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0037-2250 |
Labeler Name: | Meda Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA011792 |
Marketing Category: | NDA |
Start Marketing Date: | 20070901 |
Package NDC: | 0037-2250-10 |
Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (0037-2250-10) |
NDC Code | 0037-2250-10 |
Proprietary Name | Soma |
Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (0037-2250-10) |
Product NDC | 0037-2250 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Carisoprodol |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20070901 |
Marketing Category Name | NDA |
Labeler Name | Meda Pharmaceuticals Inc. |
Substance Name | CARISOPRODOL |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |